T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for T-CELL ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on deadly T-Cell cancers in new trial
Disease control Recruiting nowThis study tests a new treatment called CD5 CAR T cells for people with T-cell cancers that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells or cells from a donor, which are modified in a lab to better attack the cancer. The tri…
Matched conditions: T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Engineered immune cells take on tough T-Cell cancers in new trial
Disease control Recruiting nowThis study tests a new treatment called CD5-CAR T cell therapy for people with T-cell cancers that have come back or not responded to standard treatments. The therapy uses a patient's own or a donor's immune cells, modified to target and kill cancer cells. The trial will first fi…
Matched conditions: T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 01, 2026 15:59 UTC